Effective treatment of a murine model of adult T-cell leukemia using 211At-7G7/B6 and its combination with unmodified anti-Tac (daclizumab) directed toward CD25
about
Effective therapy of murine models of human leukemia and lymphoma with radiolabeled anti-CD30 antibody, HeFi-1Astatine Radiopharmaceuticals: Prospects and ProblemsTargeting of a developmentally regulated epitope of CD43 for the treatment of acute leukemia.Preclinical evaluation of an anti-CD25 monoclonal antibody, 7G7/B6, armed with the beta-emitter, yttrium-90, as a radioimmunotherapeutic agent for treating lymphoma.An overview of targeted alpha therapy.Radioimmunotherapy with α-particle-emitting radionuclides.Comparison between internalizing anti-HER2 mAbs and non-internalizing anti-CEA mAbs in alpha-radioimmunotherapy of small volume peritoneal carcinomatosis using 212Pb.Targeted alpha-particle radiotherapy with 211At-labeled monoclonal antibodies.Production of [(211)At]-astatinated radiopharmaceuticals and applications in targeted α-particle therapySerum soluble interleukin 2 receptor alpha in human cancer of adults and children: a review.Soluble interleukin-2 receptor α and interleukin-2 serum levels in patients with basal cell carcinomaReagents for astatination of biomolecules. 5. Evaluation of hydrazone linkers in (211)At- and (125)I-labeled closo-decaborate(2-) conjugates of Fab' as a means of decreasing kidney retention.Mouse Models That Enhanced Our Understanding of Adult T Cell Leukemia.
P2860
Q24685212-B414BFAD-934E-47E0-850D-DCE6C0DD8208Q33640550-9E43AF1D-9167-4868-8593-0643C7C43F37Q33944427-28B79CE5-8A7F-403D-A21B-2D0BFA93A76AQ34077332-47B723FE-93DE-4F04-AB57-7DE7EA987FE4Q34238513-71D465C5-F6E1-4014-84B4-AFA40069E634Q34419562-253DD461-D063-46C3-998B-CE288DC6BFD8Q34903258-50880C43-AE29-4DFB-A541-9BFBA30F3EEAQ36154918-7288555E-F6E9-494D-A805-CEEBC66183C6Q36534262-25FB9E6B-DED1-4C39-A484-DE57956581ADQ36956380-F470305F-CE29-438F-B336-7862CFFC134CQ37215888-2EDDDB20-AE71-486F-9358-A50CEA97EC3CQ41865540-7D71C9F1-D662-4D39-8640-FDF4891395BDQ52592925-EF64818A-4D55-4DAF-874D-49400EC5D606
P2860
Effective treatment of a murine model of adult T-cell leukemia using 211At-7G7/B6 and its combination with unmodified anti-Tac (daclizumab) directed toward CD25
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Effective treatment of a murin ...... clizumab) directed toward CD25
@ast
Effective treatment of a murin ...... clizumab) directed toward CD25
@en
type
label
Effective treatment of a murin ...... clizumab) directed toward CD25
@ast
Effective treatment of a murin ...... clizumab) directed toward CD25
@en
prefLabel
Effective treatment of a murin ...... clizumab) directed toward CD25
@ast
Effective treatment of a murin ...... clizumab) directed toward CD25
@en
P2093
P2860
P1433
P1476
Effective treatment of a murin ...... clizumab) directed toward CD25
@en
P2093
Barbara Beck
Carolyn Goldman
Kayhan Garmestani
Martin W Brechbiel
Meili Zhang
Paul S Plascjak
Thomas A Waldmann
Vladimir S Talanov
Zhuo Zhang
P2860
P304
P356
10.1182/BLOOD-2005-11-4757
P407
P577
2006-03-28T00:00:00Z